Gut microbiota's role in NAFLD- and HBV/HCV-related hepatocellular carcinoma: Mechanisms and therapeutic implications
Microbial Pathogenesis · 2026-02 · 211 · 108273
DOI: 10.1016/j.micpath.2025.108273 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbial Pathogenesis, 2026-02. Verfasst von Gursimran Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, ISF College of Pharmacy (An Autonomous College), Moga, Punjab, 142001, India. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Carcinoma, Hepatocellular, Liver Neoplasms, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 179 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy Practice, ISF College of Pharmacy (An Autonomous College), Moga, Punjab, 142001, India.
- Department of Pharmacy Practice, ISF College of Pharmacy (An Autonomous College), Moga, Punjab, 142001, India; Department of Pharmacology, ISF College of Pharmacy (An Autonomous College), Moga, Punjab, 142001, India. El…
Zitieren
APA
Singh, G., Ansari, S., Yadav, S., & Aran, K. R. (2026). Gut microbiota's role in NAFLD- and HBV/HCV-related hepatocellular carcinoma: Mechanisms and therapeutic implications. Microbial Pathogenesis, 211, 108273. https://doi.org/10.1016/j.micpath.2025.108273
Vancouver
Singh G, Ansari S, Yadav S, Aran KR. Gut microbiota's role in NAFLD- and HBV/HCV-related hepatocellular carcinoma: Mechanisms and therapeutic implications. Microbial Pathogenesis. 2026;211:108273. doi:10.1016/j.micpath.2025.108273
BibTeX
@article{Singh2026,
author = {Singh, Gursimran and Ansari, Shazia and Yadav, Satyam and Aran, Khadga Raj},
title = {Gut microbiota's role in NAFLD- and HBV/HCV-related hepatocellular carcinoma: Mechanisms and therapeutic implications},
journal = {Microbial Pathogenesis},
year = {2026},
volume = {211},
pages = {108273},
doi = {10.1016/j.micpath.2025.108273}
}
EUVIMED